Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihypertensive ergolinepropionamides.

L Bernardi, G Bosisio, S Mantegani

    Arzneimittel-Forschung
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations.

    Journal of global antimicrobial resistance·2023
    Same author

    In vitro activity of fosfomycin against mucoid and non-mucoid Pseudomonas aeruginosa strains.

    Journal of global antimicrobial resistance·2020
    Same author

    How appropriate is the use of rehabilitation facilities? Assessment by an evaluation tool based on the AEP protocol.

    Journal of preventive medicine and hygiene·2011
    Same author

    Identification of a Btk-BAG3 complex induced by oxidative stress.

    Leukemia·2009
    Same author

    Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study.

    European journal of cancer (Oxford, England : 1990)·2006
    Same author

    Cloning and expression of two plant proteins: similar antimicrobial activity of native and recombinant form.

    Biotechnology letters·2006

    Researchers synthesized novel 6-methylergoline derivatives for potential use as antihypertensive drugs. Compound 5 demonstrated promising selective antihypertensive effects in rats with low toxicity, indicating its therapeutic potential.

    Area of Science:

    • Pharmacology
    • Medicinal Chemistry
    • Drug Discovery

    Background:

    • Ergoline derivatives are explored for various therapeutic applications.
    • Hypertension remains a significant global health concern requiring novel treatments.
    • Selective antihypertensive agents with favorable safety profiles are needed.

    Purpose of the Study:

    • To synthesize and evaluate the antihypertensive activity of novel 6-methylergoline derivatives.
    • To assess the prolactin-lowering activity and acute toxicity of these compounds.
    • To establish structure-activity relationships for optimizing antihypertensive selectivity.

    Main Methods:

    • Synthesis of a series of 6-methylergolin-8 beta-yl-propionic acid derivatives.
    • In vivo evaluation of antihypertensive activity in rats.

    Related Experiment Videos

  • Assessment of prolactin-lowering activity using the nidation inhibition test in rats.
  • Acute toxicity studies in mice.

    • Main Results:

    • Several derivatives were synthesized and tested for antihypertensive and prolactin-lowering effects.
    • Modifications at the C8 side chain improved the selectivity of antihypertensive effects.
    • Introducing substituents elsewhere on the ergoline skeleton yielded unfavorable results.
    • Compound 5, 2(R,S)-cyano-3-(6-methylergolin-8 beta-yl)-propionamide, showed the most promising antihypertensive activity.

    Conclusions:

    • Structure-activity relationship studies highlight the importance of the C8 side chain for selective antihypertensive action.
    • Compound 5 is identified as a lead candidate for further development as an antihypertensive agent.
    • The synthesized ergoline derivatives offer a promising scaffold for developing safer and more selective antihypertensive drugs.